FastDetect provides an innovative point-of-care (POC) RT-PCR testing instrument that can detect active infection in COVID-19 and other diseases, with very high sensitivity (99+%) and specificity (99+%).
Problem
Solution
Media Links
Type
Focus Area
Deep Tech, Enterprise, and Sustainability
Capital Raised (US$)
6M to 20M
Operational HQ
United States
SECTOR
status
Past
founders
Todd Thomson, James Demetriades, Adrian Fawcett
partnered
2021
exited
You may be interested in...
